The role of complement and extracellular vesicles in the development of pulmonary embolism in severe COVID-19 cases
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0309112 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Gabriel Dumitrescu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anaesthesia and Intensive Care, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, and Perioperative and…. Hauptthemen laut MEDLINE: Pulmonary Embolism, COVID-19, Extracellular Vesicles, Complement System Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science for Life Laboratory, Stockholm läns landsting.
Abstract (Originalsprache)
Complement and extracellular vesicles (EVs) association with thrombogenic tendencies is acknowledged, but limited evidence exists for their link to COVID-19 venous thromboembolism. This study aims to examine the relationship between pulmonary embolism and the expression of complement and other proteins related to thrombogenesis in severe Covid-19 patients. We included prospectively 207 severe COVID-19 patients and retrospectively screened for pulmonary embolism (PE). This analysis comprises 20 confirmed PE cases and 20 matched patients without PE. Blood samples taken at the admission in the intensive care unit were analyzed for complement using ELISA. EVs derived from neutrophils, endothelium, or platelets, as well carrying complement or tissue factor were analyzed using flow cytometry. Complement levels were markedly elevated, with a notable increase in C3a and Terminal Complement Complex. The most prevalent EV population was identified as tissue factor (TF)-carrying EVs which peaked in patients with PE during ICU days 4–9. However, for both the complement and analyzed EV populations, no statistically significant differences were found between the patients who developed pulmonary embolism and those who did not. In conclusion, complement factors and EVs expressing tissue factor, along with EVs derived from endothelial cells and platelets, are elevated in severe COVID-19 patients, regardless of the presence of pulmonary embolism. However, the involvement of complement and procoagulant EVs in peripheral plasma in the development of pulmonary embolism is still unclear and requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Anaesthesia and Intensive Care, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, and Perioperative and Intensive Care Medicine, Karolinska University Hospital, Stockholm, S…
- Department of Molecular Medicine and Surgery, Karolinska Institutet, and Clinical Chemistry, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
- Division of Rheumatology, Department of Medicine, Karolinska Institutet, and Unit of Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Gabriel Dumitrescu, Apostolos Taxiarchis
Förderung
- Science for Life Laboratory
- Stockholm läns landsting
Zitieren
APA
Dumitrescu, G., Antovic, J., Soutari, N., Gran, C., Antovic, A., Al-Abani, K., Grip, J., Rooyackers, O., & Taxiarchis, A. (2024). The role of complement and extracellular vesicles in the development of pulmonary embolism in severe COVID-19 cases. PLOS ONE. https://doi.org/10.1371/journal.pone.0309112
Vancouver
Dumitrescu G, Antovic J, Soutari N, Gran C, Antovic A, Al-Abani K, et al. The role of complement and extracellular vesicles in the development of pulmonary embolism in severe COVID-19 cases. PLOS ONE. 2024. doi:10.1371/journal.pone.0309112
BibTeX
@article{Dumitrescu2024,
author = {Dumitrescu, Gabriel and Antovic, Jovan and Soutari, Nida and Gran, Charlotte and Antovic, Aleksandra and Al-Abani, Kais and Grip, Jonathan and Rooyackers, Olav and Taxiarchis, Apostolos},
title = {The role of complement and extracellular vesicles in the development of pulmonary embolism in severe COVID-19 cases},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0309112}
}
EUVIMED